IRWD
Ironwood Pharmaceuticals Inc
4.10$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.4% | 0.4% | 34.5% | 0.5% | 32.6% | 86.7% | 66.7% | 0.5% | 0.4% | 1.0% | 0.4% | – | – | |
| 99.6% | 100.0% | 65.5% | 100.0% | 67.4% | 100.0% | 33.3% | 99.5% | 99.6% | 100.0% | 99.6% | 100.0% | 99.8% | |
| 28.4% | 30.3% | 34.5% | 32.2% | 32.6% | 28.0% | 66.7% | 26.9% | 18.0% | 45.8% | 20.2% | 19.8% | 22.5% | |
| 31.7% | 32.9% | 50.2% | 39.2% | 39.4% | 37.1% | 59.0% | 19.7% | 17.9% | 40.4% | 11.3% | 10.0% | 16.6% | |
| 56.8% | 68.0% | 50.8% | 73.5% | 39.4% | 65.2% | 104.1% | 46.6% | 36.0% | 86.3% | 31.5% | 29.8% | 39.1% | |
| 42.7% | 32.0% | 14.7% | 26.5% | 28.0% | 34.8% | -70.7% | 52.9% | 63.6% | 13.7% | 68.1% | 70.2% | 60.6% | |
| 8.7% | 7.2% | 9.7% | 7.9% | 10.3% | 9.8% | 19.6% | 9.8% | 6.9% | 16.5% | 8.6% | 6.4% | 8.4% | |
| 28.1% | 25.8% | 6.6% | 20.0% | 19.0% | 26.5% | -88.2% | 44.4% | 55.7% | 1.0% | 61.2% | 65.2% | 53.3% | |
| 15.8% | 27.3% | 12.2% | 20.9% | 15.0% | 24.0% | 2.7% | 16.7% | 22.9% | 5.7% | 22.9% | 19.9% | 19.9% | |
| 13.5% | -0.9% | -5.6% | -0.9% | 4.0% | 2.5% | -90.9% | 27.7% | 32.8% | -4.8% | 38.3% | 45.4% | 33.4% | |
| 37.2% | 34.5% | 16.0% | 28.4% | 29.8% | 36.9% | -24.5% | 54.7% | 63.0% | 18.4% | 70.2% | 71.6% | 62.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.